These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20515302)

  • 1. Practical pearls in insulin pump therapy.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S23-7. PubMed ID: 20515302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
    Meneghini L; Sparrow-Bodenmiller J
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump use in adults with type 1 diabetes--practical issues.
    Shetty G; Wolpert H
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S11-6. PubMed ID: 20515299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous insulin infusion systems in type 2 diabetes.
    Kesavadev J
    J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The education of patients in prandial insulin dosing related to the structure of bolus calculators.
    Błazik M; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):301-5. PubMed ID: 21447273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 13. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Education of the patient for therapy with personal insulin pump].
    Benbenek-Klupa T
    Przegl Lek; 2006; 63(5):292-5. PubMed ID: 17036508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin delivery devices--pumps and pens.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S115-6. PubMed ID: 20515300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.